Daniel Weisdorf, MD
Deputy Director, and Clinical Translational Research Services (CTRS) core Director
Dr. Daniel Weisdorf serves as CTSI's Deputy Director and Director of its Clinical Translational Research Services (CTRS) core. As Deputy Director Dr. Weisdorf works closely with the CTSI executive leadership team to oversee the institute’s operation and achieve excellence in clinical research. In his CTRS Director role, he oversees research teams that provide a wide range of services and expert consultations to support clinical and translational research, which includes the Biostatistical Design and Analysis Center (BDAC), the Biorepository Laboratory Services (BLS), the Clinical Research Support Center (CRSC), Regulatory Support, the Workforce Development Program, and the Recruitment Program.
Dr. Weisdorf is co-leader of the Transplant Biology and Therapy Program at the Masonic Cancer Center, and serves as the Senior Research Advisor for the Center for International Blood and Marrow Transplant Research. As Professor of Medicine, Dr. Weisdorf's clinical and research interests are in application of blood and marrow transplant therapies for hematologic malignancies as well as extensive study of the clinical complications of transplantation including opportunistic infections and graft versus host disease (GVHD).
Dr. Weisdorf received his MD from the Chicago Medical School in 1975 and received Internal Medicine Training at Michael Reese Hospital in Chicago. He was a Fellow at the University of Minnesota in Hematology and Medical Oncology and is Board certified in both disciplines. Dr. Weisdorf previously served as the Scientific Director of the National Marrow Donor Program and currently is Senior Research Advisor for the Acute Leukemia Committee of the Center for International Blood & Marrow Transplant Research. He is the University of Minnesota Principal Investigator and former Steering Committee chair of the NIH-sponsored Blood and Marrow Transplant Clinical Trials Network.